Researchers offer definitive proof that T cells need to actively maintain “quiescence,” a sort of standby mode the cells enter while waiting activation by other parts of the immune system. The researchers also found that they can activate quiescent cells by targeting a single protein, opening the possibility that quiescent T cells within tumors can be used to kill cancer cells.